secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2025-10-21T23:59:59+00:00
Accession:  0001356576-25-000065
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus schedules Q3 2025 earnings release for Nov 4 after market close
------------------------------------------------------------------------

- Financial results to be released after market close on Tuesday, November 4, 2025.
- Conference call at 4:30 p.m. ET with CEO Jack Khattar and CFO Tim Dec.
- Live webcast available on Supernus investor relations website; replay for 60 days.
- No preliminary financial data provided in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657625000065/0001356576-25-000065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657625000065/supn-20251021.htm
  HTML page:      https://secwatch.observer/filing/0001356576-25-000065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer